| 2024年12月10日 - 2024年12月11日 |
What might US Food and Drug Administration enforcement look like under a new administration? Partner Jacqueline Berman will begin to unravel this question at the Food and Drug Law Institute’s 2024 Enforcement, Litigation, and Compliance Conference.
Jackie’s presentation, taking place on December 11 at 10:30 am, will cover the implications of the 2024 presidential and congressional elections with a focus on their impact to the FDA. In addition to policy predictions, this session will provide insights on the foreign inspection backlog, cross-agency collaboration, and enforcement priorities in 2025.